Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Comment by MrVerbatim9800on Dec 21, 2020 4:25pm
303 Views
Post# 32154882

RE:It take 6 weeks to process application By Nastaq

RE:It take 6 weeks to process application By NastaqApplying is the first step to being approved for the listing. When MMED initially put their application in, they had already met several of the requirments to be granted a seat on the NADSQ. If 10/10 is the qualifying bar, then they were a 6.5/10. They would be considered a 9/at this stage. The reason that the listing is imminent is that a company doesn't need to have 10/10 to be listed. A NASDQ governing board votes before allowing any company listing. Nearly all new listing to the NASDQ fail to meet 10/10 on a technical basis, but are granted the new listing based on fundamentals and potential for success. MMED will be listed..........
mingzhu wrote: MMED applied in September. Why there is still no news ? Anybody asked company?


<< Previous
Bullboard Posts
Next >>